BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2224866)

  • 1. Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding.
    Sung C; Youle RJ; Dedrick RL
    Cancer Res; 1990 Nov; 50(22):7382-92. PubMed ID: 2224866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spatial distribution of immunotoxins in solid tumors: assessment by quantitative autoradiography.
    Sung C; Dedrick RL; Hall WA; Johnson PA; Youle RJ
    Cancer Res; 1993 May; 53(9):2092-9. PubMed ID: 8481911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
    Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
    Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids.
    Wenning LA; Murphy RM
    Biotechnol Bioeng; 1999 Mar; 62(5):562-75. PubMed ID: 10099565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
    Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
    Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant immunotoxins directed against the c-erb-2/HER2/neu oncogene product: in vitro cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft models.
    Rosenblum MG; Shawver LK; Marks JW; Brink J; Cheung L; Langton-Webster B
    Clin Cancer Res; 1999 Apr; 5(4):865-74. PubMed ID: 10213223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
    Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of transferrin receptors in nude mice bearing A431 and LS174T xenografts with [18F]holo-transferrin: permeability and receptor dependence.
    Aloj L; Jogoda E; Lang L; Caracò C; Neumann RD; Sung C; Eckelman WC
    J Nucl Med; 1999 Sep; 40(9):1547-55. PubMed ID: 10492378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice.
    Baxter LT; Zhu H; Mackensen DG; Jain RK
    Cancer Res; 1994 Mar; 54(6):1517-28. PubMed ID: 8137258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells.
    Blakey DC; Skilleter DN; Price RJ; Watson GJ; Hart LI; Newell DR; Thorpe PE
    Cancer Res; 1988 Dec; 48(24 Pt 1):7072-8. PubMed ID: 3263899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure.
    Jain RK; Baxter LT
    Cancer Res; 1988 Dec; 48(24 Pt 1):7022-32. PubMed ID: 3191477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
    Roberts WG; Hasan T
    Cancer Res; 1993 Jan; 53(1):153-7. PubMed ID: 8416739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chain.
    Trown PW; Reardan DT; Carroll SF; Stoudemire JB; Kawahata RT
    Cancer Res; 1991 Aug; 51(16):4219-25. PubMed ID: 1868442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude mice.
    Spearman ME; Goodwin RM; Apelgren LD; Bumol TF
    J Pharmacol Exp Ther; 1987 May; 241(2):695-703. PubMed ID: 3494841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
    Bradley MO; Webb NL; Anthony FH; Devanesan P; Witman PA; Hemamalini S; Chander MC; Baker SD; He L; Horwitz SB; Swindell CS
    Clin Cancer Res; 2001 Oct; 7(10):3229-38. PubMed ID: 11595719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model.
    Marecos E; Weissleder R; Bogdanov A
    Bioconjug Chem; 1998; 9(2):184-91. PubMed ID: 9548533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphtheria toxin effects on brain-tumor xenografts. Implications for protein-based brain-tumor chemotherapy.
    Wrobel CJ; Wright DC; Dedrick RL; Youle RJ
    J Neurosurg; 1990 Jun; 72(6):946-50. PubMed ID: 2159988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma.
    Vallera DA; Todhunter DA; Kuroki DW; Shu Y; Sicheneder A; Chen H
    Clin Cancer Res; 2005 May; 11(10):3879-88. PubMed ID: 15897589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A C terminus cysteine of diphtheria toxin B chain involved in immunotoxin cell penetration and cytotoxicity.
    Dell'Arciprete L; Colombatti M; Rappuoli R; Tridente G
    J Immunol; 1988 Apr; 140(7):2466-71. PubMed ID: 2965187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.